116 related articles for article (PubMed ID: 7879562)
1. [The characteristics of the immune response in children having different HLA phenotypes after the first revaccination with ADTP].
Prilutskiĭ AS; Maĭlian EA; Radomskaia FS; Filippova TI; Eremin NM; Laricheva LN; Matveĭchuk LF; Klimenko TM; Karpenko VA
Zh Mikrobiol Epidemiol Immunobiol; 1994; (6):86-8. PubMed ID: 7879562
[No Abstract] [Full Text] [Related]
2. [The efficacy of the ADTP-vaccine immunization of children with different courses of the vaccinal period].
Sliusar' LI; Romanenko TA; Dubil'er Zhi ; Panasenko LI; Litvinova TP
Pediatriia; 1992; (10-12):22-5. PubMed ID: 1291954
[No Abstract] [Full Text] [Related]
3. [The characteristics of the development of immunity with a primary immunization complex using adsorbed DTP vaccine].
Kosenkova TV; Fedorov GN; Naperstnikov VV; Grigor'eva VN; Koliasnikova IV; Stefani DV
Zh Mikrobiol Epidemiol Immunobiol; 2000; (3):55-8. PubMed ID: 10925876
[TBL] [Abstract][Full Text] [Related]
4. Clinical reactions and immunogenicity of the BIKEN acellular diphtheria and tetanus toxoids and pertussis vaccine in 4- through 6-year-old US children.
Bernstein HH; Rothstein EP; Pichichero ME; Francis AB; Kovel AJ; Disney FA; Green JL; Marsocci SM; Lynd AM; Wood GC
Am J Dis Child; 1992 May; 146(5):556-9. PubMed ID: 1621656
[TBL] [Abstract][Full Text] [Related]
5. [Study on immune persistency of combined diphtheria-pertussis-tetanus (DPT) triple vaccine].
Diao L
Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Feb; 13(1):26-9. PubMed ID: 1581951
[TBL] [Abstract][Full Text] [Related]
6. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
[TBL] [Abstract][Full Text] [Related]
7. [The adsorbed-DTP-m vaccination of children with allergically altered reactivity].
Kostinov MP; Balabolkin II; Sigaeva LA; Reutova VS; Bogatyreva EIa
Zh Mikrobiol Epidemiol Immunobiol; 1995; (1):44-9. PubMed ID: 7778374
[TBL] [Abstract][Full Text] [Related]
8. A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults.
Van der Wielen M; Van Damme P; Joossens E; François G; Meurice F; Ramalho A
Vaccine; 2000 Apr; 18(20):2075-82. PubMed ID: 10715521
[TBL] [Abstract][Full Text] [Related]
9. [The revaccination against diphtheria and tetanus with adsorbed DT-m anatoxin of children having solid tumors in their case histories].
Karpocheva SV; Kostinov MP; Zaeva GE; Gurvich EB; Zaĭtseva LA; Gavrilova GL; Korotkova OV; Kuznetsova AV
Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):46-9. PubMed ID: 10852050
[TBL] [Abstract][Full Text] [Related]
10. [The effect of nematode invasiveness in children on postvaccinal immunity].
Lysenko AIa; Fel'dman EV; Rybak EA
Med Parazitol (Mosk); 1991; (5):34-6. PubMed ID: 1836830
[No Abstract] [Full Text] [Related]
11. Comparison of antibody titers in eleven- to twelve-year old Japanese school children six years after administration of acellular and whole cell pertussis vaccines combined with diphtheria-tetanus toxoids.
Okada K; Ueda K; Morokuma K; Fukushige J; Miyazaki C
Pediatr Infect Dis J; 1998 Dec; 17(12):1167-9. PubMed ID: 9877371
[No Abstract] [Full Text] [Related]
12. [The evaluation of the efficacy of a first course of immunization against diphtheria and tetanus in children with kidney diseases].
Magarshak OO; Kostinov MP; Sergeeva TV; Kapitonova ME
Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):43-6. PubMed ID: 10852049
[TBL] [Abstract][Full Text] [Related]
13. [The relationship of the intensity of antibody formation to the causative agents of diphtheria and tetanus to genetic markers in children vaccinated with adsorbed DPT].
Prilutskiĭ AS; Sokhin AA; Maĭlian EA; Koteneva GE; Lugovaia IuV
Zh Mikrobiol Epidemiol Immunobiol; 1994; (2):89-92. PubMed ID: 8017136
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the reactogenicity and immunogenic potency of combined vaccine "Bubo-Kok" in the immunization of children against diphtheria, tetanus, pertussis and viral hepatitis B].
Fel'dblium IV; Nikolaeva AM; Kuz'ianin AV; Borisova VN; Mel'nikov VA; Chuprinina RP; Perelygina OV; Shalunova NV; Semenova VD; Griaznova DV; Pushkareva EV; Uvitskiĭ AIu; Alekseeva IA; Konopleva OA; Budanov MV; Iakovleva IM
Zh Mikrobiol Epidemiol Immunobiol; 2004; (5):58-62. PubMed ID: 15554315
[TBL] [Abstract][Full Text] [Related]
15. Antibody level of New Zealand children immunized with the triple vaccine DTP (diphtheria-tetanus-pertussis).
Lau RC
Epidemiol Infect; 1988 Oct; 101(2):405-10. PubMed ID: 2903065
[TBL] [Abstract][Full Text] [Related]
16. Antibody response to diphtheria-tetanus-pertussis immunization in preterm infants who receive dexamethasone for chronic lung disease.
Robinson MJ; Heal C; Gardener E; Powell P; Sims DG
Pediatrics; 2004 Apr; 113(4):733-7. PubMed ID: 15060220
[TBL] [Abstract][Full Text] [Related]
17. [Antibody response to the fractionated administration of the 2d or 3d basic vaccination injection with a mixed vaccine against diphtheria, tetanus and pertussis].
Vodicková M; Svandová E
Cesk Pediatr; 1986 Jun; 41(6):321-3. PubMed ID: 2872973
[No Abstract] [Full Text] [Related]
18. Definition of minimum standards for immunogenicity--potential problems of serological correlates--possible interference. Serological correlates for diphtheria-tetanus-whole cell pertussis vaccines.
Heron I
Biologicals; 1994 Dec; 22(4):389-90. PubMed ID: 7779366
[No Abstract] [Full Text] [Related]
19. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
[TBL] [Abstract][Full Text] [Related]
20. [Reactogenic properties of a DTP vaccine with a reduced antigen dosage].
Baeva EA; Selezneva TS; Kucherovskaia TV; Auzinia AV; Glinskaia EV
Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):47-50. PubMed ID: 2879401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
